BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1823836)

  • 1. Radiolabelled metaiodobenzylguanidine targeted radiotherapy for malignant phaeochromocytoma.
    Lewington VJ; Zivanovic MA; Tristam M; McEwan AJ; Ackery DM
    J Nucl Biol Med (1991); 1991; 35(4):280-3. PubMed ID: 1823836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of [131I]metaiodobenzylguanidine therapy administered to three patients with malignant pheochromocytoma.
    Schvartz C; Gibold C; Vuillemin B; Delisle MJ
    J Nucl Biol Med (1991); 1991; 35(4):305-7. PubMed ID: 1823842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of [131I]metaiodobenzylguanidine treatment in metastatic malignant phaeochromocytoma.
    Bestagno M; Pizzocaro C; Maira G; Terzi A; Panarotto MB; Guerra P
    J Nucl Biol Med (1991); 1991; 35(4):277-9. PubMed ID: 1823835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Session on the role of [131I]metaiodobenzylguanidine in the treatment of malignant phaeochromocytoma. Chairmen's report.
    Ackery DM; Troncone L
    J Nucl Biol Med (1991); 1991; 35(4):318-20. PubMed ID: 1823846
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapy of pheochromocytoma with [131I]metaiodobenzylguanidine.
    Fischer M
    J Nucl Biol Med (1991); 1991; 35(4):292-4. PubMed ID: 1823839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 131I-MIBG therapy of neural crest tumours (review).
    Troncone L; Rufini V
    Anticancer Res; 1997; 17(3B):1823-31. PubMed ID: 9179240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic possibilities in metastatic pheochromocytoma].
    Vierhapper H; Raber W
    Zentralbl Chir; 1997; 122(6):494-7. PubMed ID: 9334119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [131I]metaiodobenzylguanidine therapy of malignant pheochromocytoma: interference of medication.
    Hoefnagel CA; Schornagel J; Valdés Olmos RA
    J Nucl Biol Med (1991); 1991; 35(4):308-12. PubMed ID: 1823843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [131I]metaiodobenzylguanidine therapy in 20 patients with malignant pheochromocytoma.
    Lumbroso J; Schlumberger M; Tenenbaum F; Aubert B; Travagli JP; Parmentier C
    J Nucl Biol Med (1991); 1991; 35(4):288-91. PubMed ID: 1823838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of malignant pheochromocytoma using I-131 metaiodobenzylguanidine--report of a case].
    Okazawa H; Endo K; Saga T; Watanabe Y; Nakai T; Kasagi K; Konishi J; Abe M; Goto K; Nakao K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Mar; 50(3):286-94. PubMed ID: 2345700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic phaeochromocytoma with a long-term response after iodine-131 metaiodobenzylguanidine therapy.
    Pujol P; Bringer J; Faurous P; Jaffiol C
    Eur J Nucl Med; 1995 Apr; 22(4):382-4. PubMed ID: 7607270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [131I]metaiodobenzylguanidine treatment of malignant pheochromocytoma: experience of the Rome group.
    Troncone L; Rufini V; Daidone MS; De Santis M; Luzi S
    J Nucl Biol Med (1991); 1991; 35(4):295-9. PubMed ID: 1823840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiopharmaceutical therapy of malignant pheochromocytoma with [131I]metaiodobenzylguanidine: results from ten years of experience.
    Shapiro B; Sisson JC; Wieland DM; Mangner TJ; Zempel SM; Mudgett E; Gross MD; Carey JE; Zasadny KR; Beierwaltes WH
    J Nucl Biol Med (1991); 1991; 35(4):269-76. PubMed ID: 1823834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary results of [131]metaiodobenzylguanidine treatment in metastatic malignant pheochromocytoma.
    Colombo L; Lomuscio G; Vignati A; Dottorini ME
    J Nucl Biol Med (1991); 1991; 35(4):300-4. PubMed ID: 1823841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nuclear medical therapy of pheochromocytoma].
    Fischer M; Winterberg B; Zidek W; Müller-Rensing R; Vetter H
    Schweiz Med Wochenschr; 1984 Dec; 114(49):1841-3. PubMed ID: 6515381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of malignant phaeochromocytoma, paraganglioma and carcinoid tumours with 131I-metaiodobenzylguanidine.
    Bomanji J; Britton KE; Ur E; Hawkins L; Grossman AB; Besser GM
    Nucl Med Commun; 1993 Oct; 14(10):856-61. PubMed ID: 8233228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [131I]metaiodobenzylguanidine therapy in paraganglioma.
    Castellani MR; Rottoli L; Maffioli L; Massimino M; Crippa F; Buraggi GL
    J Nucl Biol Med (1991); 1991; 35(4):315-7. PubMed ID: 1823845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of malignant pheochromocytoma with [131I]metaiodobenzylguanidine: a French multicenter study.
    Krempf M; Lumbroso J; Mornex R; Brendel AJ; Wemeau JL; Delisle MJ; Aubert B; Carpentier P; Fleury-Goyon MC; Gibold C
    J Nucl Biol Med (1991); 1991; 35(4):284-7. PubMed ID: 1823837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification by nifedipine of 131I-meta-iodobenzylguanidine kinetics in malignant phaeochromocytoma.
    Blake GM; Lewington VJ; Fleming JS; Zivanovic MA; Ackery DM
    Eur J Nucl Med; 1988; 14(7-8):345-8. PubMed ID: 3181183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of I-131-meta-iodobenzylguanidine in the treatment of malignant pheochromocytoma. Description of 2 cases].
    Jakubowski W; Feltynowski T; Woy-Wojciechowski J; Leowska E; Liziniewicz A
    Pol Tyg Lek; 1986 Oct; 41(43):1386-8. PubMed ID: 3822916
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.